Covid: US backs waiver on vaccine intellectual property
Supporters say the move would boost vaccine production but the pharmaceutical industry disagrees.
Follow Our Network On LinkedIn: Follow link
Supporters say the move would boost vaccine production but the pharmaceutical industry disagrees.
